Clinical trial
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin…
NCT00491530 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00491530 |
|---|---|
| Title | A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia |
| Official title | A Year 2, Long-Term, Open-Label, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mixed Dyslipidemia |
| Intervention type | Drug |
| Interventions | ABT-335, rosuvastatin calcium, simvastatin, atorvastatin calcium |
| Enrollment | 310 |
| Start date | Jun 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jun 26, 2007 |
| Last update posted | Jan 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: